Status:
UNKNOWN
Coagulopathy in COVID19 - A Multi-Centre Observational Study in UK
Lead Sponsor:
Imperial College London
Conditions:
COVID
Thrombosis
Eligibility:
All Genders
18+ years
Brief Summary
A novel Coronavirus (COVID-19) infection leading to pneumonia and severe acute respiratory failure \[acute respiratory distress syndrome (ARDS)\] and death is a global threat. On 11/03/2020, WHO decla...
Eligibility Criteria
Inclusion
- Adult patients (\>18 years) admitted hospitals with COVID 19 infection (COVID RNA+ +/- radiological change +/- clinical suspicion in absence of RNA)
Exclusion
- No exclusions
Key Trial Info
Start Date :
May 25 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 25 2021
Estimated Enrollment :
5000 Patients enrolled
Trial Details
Trial ID
NCT04405232
Start Date
May 25 2020
End Date
June 25 2021
Last Update
July 31 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Imperial College Healthcare NHS Trust
London, United Kingdom